Interventional Cardiology

Filter

Calcified Lesions: AI-Driven μQFR Offers Viable Alternative to Fractional Flow Reserve

April 2025

μQFR shows moderate accuracy for calcified coronary lesions, offering a wire-free FFR alternative.

Coronary Events After TAVR: Key Findings from the France-TAVI Registry

Coronary events post-TAVR are uncommon but serious. Patients undergoing PCI have better outcomes, especially with balloon-expandable valves.

Myval Transcatheter Heart Valve Matches SAPIEN and Evolut in 30-Day Performance

The Myval THV series is non-inferior to SAPIEN and Evolut THV series at 30 days, offering a promising TAVI alternative.

Polymer-Free versus Biodegradable Stents: New Insights into Safety and Efficacy

Polymer-free stents match biodegradable-polymer stents in PCI outcomes but pose a higher early thrombosis risk, requiring careful clinical consideration.

Photon-Counting CT Improves Accuracy and Optimises CAD Treatment Pathways

Photon-counting CT outperforms conventional imaging for coronary artery disease, reducing invasive procedures and improving accuracy.

TRILUMINATE Imaging Substudy: Sustained Cardiac Remodelling with TriClip

New imaging data show TriClip reduces tricuspid regurgitation and reverses cardiac remodeling, sustaining benefits for one year.

Wearable Technology Revolutionises Subclinical Leaflet Thrombosis Detection After TAVR

Innovative wearable ACG technology shows promise as a non-invasive diagnostic tool for SLT after TAVR.

Higher Risks of Bacteraemia and Infective Endocarditis after TAVI

Higher rates of bacteraemia and infective endocarditis occur after TAVI compared with CAG, suggesting tailored antibiotic prophylaxis.

5-Year Outcomes of Valve Type and Anaesthesia Strategy for TAVR

SEV and BEV valves with CS or GA yield similar TAVR outcomes; CS lowers mortality and SEVs reduce stroke risk.

Loading posts...

« Previous 1 2 3 4 5 … 10 Next »